CELU and CELUW Related Headlines
Go Back- Celularity CEO comments on Medicare skin substitute rule withdrawal
- Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
- Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance
- Celularity Receives Nasdaq Notice Regarding Form 10-Q
- Celularity retires $41.6 million senior secured debt through IP sale
- Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt
- Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
- Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies
- Celularity (CELU) Announces CFO Transition
- Celularity Announces Chief Financial Officer Transition
CELU and CELUW Related Press Releases
Go Back- Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
- Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance
- Celularity Receives Nasdaq Notice Regarding Form 10-Q
- Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt
- Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
- Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies
- Celularity Announces Chief Financial Officer Transition
